Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Cp (NQ: TECH )

77.56 +1.96 (+2.59%)
Streaming Delayed Price Updated: 3:01 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 893,746
Open 76.89
Bid (Size) 77.48 (1)
Ask (Size) 77.55 (1)
Prev. Close 75.60
Today's Range 76.18 - 77.91
52wk Range 51.79 - 89.91
Shares Outstanding 157,191,685
Dividend Yield 0.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
TECH stock results show that Bio-Techne beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace

Performance

YTD
+1.11%
+1.11%
1 Month
+12.80%
+12.80%
3 Month
+13.16%
+13.16%
6 Month
+39.97%
+39.97%
1 Year
-9.79%
-9.79%

More News

Read More
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Navigating 4 Analyst Ratings For Bio-Techne
Via Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Via InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
Via Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
Via InvestorPlace
Earnings Outlook For Bio-Techne
Via Benzinga
Expert Ratings for Bio-Techne
Via Benzinga
Earnings Preview: Bio-Techne
Via Benzinga
Bio-Techne's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Via Benzinga
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
Via Benzinga
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
Via InvestorPlace
Advancing with Stability: Bio-Techne Benefits Investors with Growing Earnings and Stable Payouts
Via Benzinga
3 AI Stock-Split Stocks to Buy Now
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Healthcare Stocks to Keep an Eye On
Via The Motley Fool
Nurturing Growth: Bio-Techne Supports Investors with Growing Earnings
Via Benzinga
Earnings Scheduled For February 1, 2024
Via Benzinga
Earnings Scheduled For October 31, 2023
Via Benzinga
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
Via InvestorPlace
Life Science Firm Bio-Techne's Success Formula: Astute Acquisitions Offering Transformation
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.